Table 3 Risk stratification of CLNM based on the nomograms.

From: Construction and validation of nomograms to predict central lymph node metastasis in clinical node-negative unilateral papillary thyroid carcinoma

 

Ipsilateral CLNM

Contralateral CLNM

Risk group

Proportion (%)

Score

Risk (%)

Proportion (%)

Score

Risk (%)

Low risk group

33

< 74

< 25

33

< 72

< 15

Moderate-risk group

33

74–99

25–50

33

72–100

15–25

High risk group

34

> 99

> 50

34

> 100

> 25

Back to article page